nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—DRD4—Gilles de la Tourette syndrome	0.286	0.342	CbGaD
Iloperidone—DRD3—Gilles de la Tourette syndrome	0.247	0.295	CbGaD
Iloperidone—DRD2—Gilles de la Tourette syndrome	0.171	0.204	CbGaD
Iloperidone—HTR2A—Gilles de la Tourette syndrome	0.132	0.158	CbGaD
Iloperidone—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00424	0.104	CbGeAlD
Iloperidone—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00264	0.065	CbGeAlD
Iloperidone—Paliperidone—DRD4—Gilles de la Tourette syndrome	0.00131	0.17	CrCbGaD
Iloperidone—DRD4—brain—Gilles de la Tourette syndrome	0.0013	0.0321	CbGeAlD
Iloperidone—DRD3—nervous system—Gilles de la Tourette syndrome	0.0012	0.0295	CbGeAlD
Iloperidone—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00115	0.0284	CbGeAlD
Iloperidone—HTR6—nervous system—Gilles de la Tourette syndrome	0.00115	0.0284	CbGeAlD
Iloperidone—Paliperidone—DRD3—Gilles de la Tourette syndrome	0.00113	0.146	CrCbGaD
Iloperidone—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00111	0.0273	CbGeAlD
Iloperidone—DRD1—midbrain—Gilles de la Tourette syndrome	0.00104	0.0257	CbGeAlD
Iloperidone—Risperidone—DRD4—Gilles de la Tourette syndrome	0.000973	0.126	CrCbGaD
Iloperidone—DRD3—brain—Gilles de la Tourette syndrome	0.000917	0.0225	CbGeAlD
Iloperidone—HTR6—brain—Gilles de la Tourette syndrome	0.000882	0.0217	CbGeAlD
Iloperidone—DRD1—nervous system—Gilles de la Tourette syndrome	0.000859	0.0211	CbGeAlD
Iloperidone—Risperidone—DRD3—Gilles de la Tourette syndrome	0.000839	0.109	CrCbGaD
Iloperidone—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000827	0.0203	CbGeAlD
Iloperidone—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000819	0.0202	CbGeAlD
Iloperidone—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000811	0.02	CbGeAlD
Iloperidone—Paliperidone—DRD2—Gilles de la Tourette syndrome	0.000779	0.101	CrCbGaD
Iloperidone—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.000764	0.0188	CbGeAlD
Iloperidone—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000683	0.0168	CbGeAlD
Iloperidone—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000674	0.0166	CbGeAlD
Iloperidone—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000667	0.0164	CbGeAlD
Iloperidone—DRD1—brain—Gilles de la Tourette syndrome	0.000656	0.0161	CbGeAlD
Iloperidone—HTR7—midbrain—Gilles de la Tourette syndrome	0.000653	0.0161	CbGeAlD
Iloperidone—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000649	0.0159	CbGeAlD
Iloperidone—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000642	0.0158	CbGeAlD
Iloperidone—DRD2—midbrain—Gilles de la Tourette syndrome	0.000617	0.0152	CbGeAlD
Iloperidone—Paliperidone—HTR2A—Gilles de la Tourette syndrome	0.000602	0.0782	CrCbGaD
Iloperidone—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.0006	0.0148	CbGeAlD
Iloperidone—Cisapride—DRD2—Gilles de la Tourette syndrome	0.00059	0.0767	CrCbGaD
Iloperidone—Risperidone—DRD2—Gilles de la Tourette syndrome	0.000581	0.0754	CrCbGaD
Iloperidone—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000561	0.0138	CbGeAlD
Iloperidone—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000541	0.0133	CbGeAlD
Iloperidone—HTR7—nervous system—Gilles de la Tourette syndrome	0.000537	0.0132	CbGeAlD
Iloperidone—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000518	0.0127	CbGeAlD
Iloperidone—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000517	0.0127	CbGeAlD
Iloperidone—HTR1D—brain—Gilles de la Tourette syndrome	0.000515	0.0127	CbGeAlD
Iloperidone—HTR2C—brain—Gilles de la Tourette syndrome	0.00051	0.0125	CbGeAlD
Iloperidone—DRD2—nervous system—Gilles de la Tourette syndrome	0.000507	0.0125	CbGeAlD
Iloperidone—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000498	0.0123	CbGeAlD
Iloperidone—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000493	0.0121	CbGeAlD
Iloperidone—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000488	0.012	CbGeAlD
Iloperidone—SIGMAR1—brain—Gilles de la Tourette syndrome	0.00048	0.0118	CbGeAlD
Iloperidone—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000479	0.0118	CbGeAlD
Iloperidone—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000475	0.0117	CbGeAlD
Iloperidone—Cisapride—HTR2A—Gilles de la Tourette syndrome	0.000456	0.0592	CrCbGaD
Iloperidone—Risperidone—HTR2A—Gilles de la Tourette syndrome	0.000449	0.0583	CrCbGaD
Iloperidone—HTR1A—brain—Gilles de la Tourette syndrome	0.000429	0.0106	CbGeAlD
Iloperidone—HTR7—brain—Gilles de la Tourette syndrome	0.00041	0.0101	CbGeAlD
Iloperidone—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000407	0.01	CbGeAlD
Iloperidone—HRH1—nervous system—Gilles de la Tourette syndrome	0.000401	0.00985	CbGeAlD
Iloperidone—ADRA1A—brain—Gilles de la Tourette syndrome	0.000396	0.00973	CbGeAlD
Iloperidone—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000394	0.00968	CbGeAlD
Iloperidone—DRD2—brain—Gilles de la Tourette syndrome	0.000388	0.00954	CbGeAlD
Iloperidone—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000386	0.00949	CbGeAlD
Iloperidone—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.000385	0.00947	CbGeAlD
Iloperidone—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000379	0.00932	CbGeAlD
Iloperidone—ADRA2C—brain—Gilles de la Tourette syndrome	0.000377	0.00927	CbGeAlD
Iloperidone—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.000371	0.00912	CbGeAlD
Iloperidone—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000335	0.00823	CbGeAlD
Iloperidone—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000322	0.00792	CbGeAlD
Iloperidone—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00031	0.00762	CbGeAlD
Iloperidone—HRH1—brain—Gilles de la Tourette syndrome	0.000306	0.00753	CbGeAlD
Iloperidone—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000305	0.0075	CbGeAlD
Iloperidone—ADRA2A—brain—Gilles de la Tourette syndrome	0.000301	0.0074	CbGeAlD
Iloperidone—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000298	0.00733	CbGeAlD
Iloperidone—CYP2E1—brain—Gilles de la Tourette syndrome	0.000294	0.00724	CbGeAlD
Iloperidone—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000293	0.00722	CbGeAlD
Iloperidone—HTR2A—brain—Gilles de la Tourette syndrome	0.000256	0.00629	CbGeAlD
Iloperidone—CYP2D6—brain—Gilles de la Tourette syndrome	0.000233	0.00573	CbGeAlD
Iloperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	7.9e-05	0.000677	CbGpPWpGaD
Iloperidone—DRD4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.89e-05	0.000676	CbGpPWpGaD
Iloperidone—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.85e-05	0.000673	CbGpPWpGaD
Iloperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.78e-05	0.000667	CbGpPWpGaD
Iloperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.76e-05	0.000665	CbGpPWpGaD
Iloperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.66e-05	0.000656	CbGpPWpGaD
Iloperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.64e-05	0.000655	CbGpPWpGaD
Iloperidone—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.62e-05	0.000653	CbGpPWpGaD
Iloperidone—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.62e-05	0.000653	CbGpPWpGaD
Iloperidone—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.59e-05	0.00065	CbGpPWpGaD
Iloperidone—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.58e-05	0.000649	CbGpPWpGaD
Iloperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.56e-05	0.000647	CbGpPWpGaD
Iloperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.54e-05	0.000646	CbGpPWpGaD
Iloperidone—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.53e-05	0.000645	CbGpPWpGaD
Iloperidone—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.52e-05	0.000644	CbGpPWpGaD
Iloperidone—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.52e-05	0.000644	CbGpPWpGaD
Iloperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.5e-05	0.000643	CbGpPWpGaD
Iloperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.44e-05	0.000637	CbGpPWpGaD
Iloperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.42e-05	0.000636	CbGpPWpGaD
Iloperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	7.35e-05	0.00063	CbGpPWpGaD
Iloperidone—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	7.31e-05	0.000626	CbGpPWpGaD
Iloperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.28e-05	0.000624	CbGpPWpGaD
Iloperidone—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.25e-05	0.000622	CbGpPWpGaD
Iloperidone—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	7.17e-05	0.000615	CbGpPWpGaD
Iloperidone—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.1e-05	0.000608	CbGpPWpGaD
Iloperidone—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.01e-05	0.0006	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	6.97e-05	0.000597	CbGpPWpGaD
Iloperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.93e-05	0.000593	CbGpPWpGaD
Iloperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.91e-05	0.000592	CbGpPWpGaD
Iloperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.78e-05	0.000581	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.76e-05	0.00058	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.75e-05	0.000578	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.72e-05	0.000575	CbGpPWpGaD
Iloperidone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.55e-05	0.000562	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.55e-05	0.000562	CbGpPWpGaD
Iloperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.54e-05	0.00056	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.53e-05	0.00056	CbGpPWpGaD
Iloperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.53e-05	0.00056	CbGpPWpGaD
Iloperidone—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.52e-05	0.000559	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.52e-05	0.000559	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	6.45e-05	0.000553	CbGpPWpGaD
Iloperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.44e-05	0.000552	CbGpPWpGaD
Iloperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	6.41e-05	0.00055	CbGpPWpGaD
Iloperidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.34e-05	0.000543	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.34e-05	0.000543	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.3e-05	0.00054	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	6.26e-05	0.000537	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.11e-05	0.000523	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.07e-05	0.00052	CbGpPWpGaD
Iloperidone—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.93e-05	0.000508	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.91e-05	0.000506	CbGpPWpGaD
Iloperidone—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.83e-05	0.0005	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.82e-05	0.000499	CbGpPWpGaD
Iloperidone—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.78e-05	0.000495	CbGpPWpGaD
Iloperidone—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.77e-05	0.000494	CbGpPWpGaD
Iloperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.75e-05	0.000493	CbGpPWpGaD
Iloperidone—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.75e-05	0.000493	CbGpPWpGaD
Iloperidone—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.73e-05	0.000491	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.71e-05	0.000489	CbGpPWpGaD
Iloperidone—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.66e-05	0.000485	CbGpPWpGaD
Iloperidone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.65e-05	0.000484	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.65e-05	0.000484	CbGpPWpGaD
Iloperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.62e-05	0.000481	CbGpPWpGaD
Iloperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.59e-05	0.000479	CbGpPWpGaD
Iloperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.54e-05	0.000475	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.54e-05	0.000475	CbGpPWpGaD
Iloperidone—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.52e-05	0.000473	CbGpPWpGaD
Iloperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.43e-05	0.000466	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.31e-05	0.000455	CbGpPWpGaD
Iloperidone—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.27e-05	0.000452	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.26e-05	0.000451	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.16e-05	0.000443	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.15e-05	0.000442	CbGpPWpGaD
Iloperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.15e-05	0.000441	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.15e-05	0.000441	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.15e-05	0.000441	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.11e-05	0.000438	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	5.09e-05	0.000436	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5e-05	0.000429	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5e-05	0.000428	CbGpPWpGaD
Iloperidone—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000426	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.97e-05	0.000425	CbGpPWpGaD
Iloperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.93e-05	0.000422	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.93e-05	0.000422	CbGpPWpGaD
Iloperidone—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.91e-05	0.00042	CbGpPWpGaD
Iloperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.84e-05	0.000415	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000411	CbGpPWpGaD
Iloperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.75e-05	0.000407	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.68e-05	0.000401	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.68e-05	0.000401	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	4.67e-05	0.0004	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	4.66e-05	0.000399	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.66e-05	0.000399	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.66e-05	0.000399	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.64e-05	0.000398	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.63e-05	0.000396	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000389	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000389	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.51e-05	0.000386	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.48e-05	0.000383	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.46e-05	0.000382	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.44e-05	0.00038	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.41e-05	0.000378	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.31e-05	0.000369	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.28e-05	0.000366	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.25e-05	0.000365	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.25e-05	0.000364	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000363	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000362	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.2e-05	0.00036	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.14e-05	0.000355	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.05e-05	0.000347	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.03e-05	0.000345	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.01e-05	0.000344	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.96e-05	0.000339	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.91e-05	0.000335	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.86e-05	0.000331	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.82e-05	0.000327	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.8e-05	0.000325	CbGpPWpGaD
Iloperidone—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.75e-05	0.000322	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.7e-05	0.000317	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.69e-05	0.000316	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.69e-05	0.000316	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.68e-05	0.000316	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.64e-05	0.000312	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.62e-05	0.00031	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.6e-05	0.000308	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.58e-05	0.000307	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.46e-05	0.000297	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.45e-05	0.000296	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.45e-05	0.000295	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.43e-05	0.000294	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.36e-05	0.000288	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.000288	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.35e-05	0.000287	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.35e-05	0.000287	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.35e-05	0.000287	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.34e-05	0.000286	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.32e-05	0.000284	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.3e-05	0.000282	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.29e-05	0.000282	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.26e-05	0.00028	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.26e-05	0.000279	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.25e-05	0.000279	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.25e-05	0.000279	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.24e-05	0.000278	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.23e-05	0.000277	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.2e-05	0.000274	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.19e-05	0.000274	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.13e-05	0.000268	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.13e-05	0.000268	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.12e-05	0.000267	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.12e-05	0.000267	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.04e-05	0.000261	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.03e-05	0.00026	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3e-05	0.000257	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.99e-05	0.000256	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.99e-05	0.000256	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.98e-05	0.000255	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000255	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.96e-05	0.000254	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.96e-05	0.000254	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.95e-05	0.000253	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.000252	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.93e-05	0.000251	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.92e-05	0.00025	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.91e-05	0.000249	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.91e-05	0.000249	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.9e-05	0.000248	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.85e-05	0.000244	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.83e-05	0.000243	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000241	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.81e-05	0.000241	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.77e-05	0.000238	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.76e-05	0.000237	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.76e-05	0.000237	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.74e-05	0.000235	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000233	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.71e-05	0.000232	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.71e-05	0.000232	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.7e-05	0.000231	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.68e-05	0.00023	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.68e-05	0.00023	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.66e-05	0.000228	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.65e-05	0.000227	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.64e-05	0.000227	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000227	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.000219	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.52e-05	0.000216	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.5e-05	0.000214	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.5e-05	0.000214	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.48e-05	0.000213	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.000211	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.42e-05	0.000207	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000206	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.39e-05	0.000205	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000204	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.34e-05	0.0002	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000198	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000195	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000188	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.18e-05	0.000187	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.17e-05	0.000186	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.15e-05	0.000184	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.12e-05	0.000182	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.12e-05	0.000182	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.12e-05	0.000182	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000178	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.05e-05	0.000175	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.04e-05	0.000175	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.04e-05	0.000174	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.00017	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.98e-05	0.00017	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.98e-05	0.000169	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.000165	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.92e-05	0.000165	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.9e-05	0.000163	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.89e-05	0.000162	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000158	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.8e-05	0.000154	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.79e-05	0.000153	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.77e-05	0.000151	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.76e-05	0.000151	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.75e-05	0.00015	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.75e-05	0.00015	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.74e-05	0.000149	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000149	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.73e-05	0.000148	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000148	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000147	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.71e-05	0.000147	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.68e-05	0.000144	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.67e-05	0.000143	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.61e-05	0.000138	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000137	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000137	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.57e-05	0.000134	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000134	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000129	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000127	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.45e-05	0.000125	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.3e-05	0.000111	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.29e-05	0.000111	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.25e-05	0.000107	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.14e-05	9.75e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.12e-05	9.58e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.1e-05	9.4e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.02e-05	8.73e-05	CbGpPWpGaD
